Research and development - Press Releases

Date	Title	Company
23-Dec-2022	Alfa Chemistry Enriches API Supply by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban	Alfa Chemistry
23-Dec-2022	CD Formulation Launches One-stop OEM/ODM and Analytical Testing Solutions for Cosmetics	CD Formulation
23-Dec-2022	Nearly 480 Cosmetic Ingredients Are Now Available at CD Formulation	CD Formulation
22-Dec-2022	Kancera submits regulatory application to conduct clinical study in ovarian cancer and enters into collaboration with the Nordic Society of Gynaecological Oncology	Kancera
20-Dec-2022	2cureX reaches 2022 geographic rollout goal of 20 countries	2cureX
16-Dec-2022	Alchemab Therapeutics and Medicines Discovery Catapult Awarded £1.7 Million Grant From Innovate UK to Accelerate Development of Disease-Modifying Therapy for Huntington’s Disease	Medicines Discovery Catapult
14-Dec-2022	Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture	SAE Media Group
14-Dec-2022	Quartic.ai Addresses Process Development Capacity Constraints with AI-Powered PD Optimization	Quartic.ai
14-Dec-2022	GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets	GSK
13-Dec-2022	Abingworth appoints experienced life sciences investor Joy Ghosh, PhD as Managing Director	Abingworth
13-Dec-2022	Oxford Science Enterprises’ Portfolio Company OxfordVR to Combine with BehaVR to Confront the Mental Health Crisis with the Largest VR Delivery Platform for Evidence-Based Digital Therapeutics	Oxford Science Enterprises
13-Dec-2022	NEW 3D-PRINTING MATERIAL AND FASTEST HIGH PRECISION PRINTER CREATE HUMAN BODY-LIKE MICRO-ENVIRONMENT	UpNano
13-Dec-2022	Technology training lacking for over half of manufacturers	Visual Components
13-Dec-2022	Blood clotting research holds hope for sepsis	University of Birmingham
13-Dec-2022	PLANNING APPLICATION SUBMITTED AT CANARY WHARF FOR EUROPE’S LARGEST AND MOST TECHNOLOGICALLY ADVANCED LIFE SCIENCES BUILDING	Canary Wharf Group
13-Dec-2022	Green Bioactives completes £2.6m seed financing to advance its sustainable plant products biomanufacturing platform	Green Bioactives
13-Dec-2022	Sosei Heptares Receives $10 Million Milestone Payment in Discovery Collaboration with AbbVie Targeting Inflammatory Diseases	Sosei Heptares
13-Dec-2022	Kindeva and Meridian Combine: Create Leading Drug-Device Combination Product CDMO	Kindeva
13-Dec-2022	PureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual Meeting	PureTech
13-Dec-2022	Genomic Biopharma and patient advocacy organization POIC e dintorni APS partner to offer whole genome sequencing to bring better treatments and cures to those living with gastrointestinal diseases	Genomic Biopharma